Stay updated on Botensilimab for Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Botensilimab for Advanced Melanoma Clinical Trial page.

Latest updates to the Botensilimab for Advanced Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe page history now includes a new revision label, v3.3.4, indicating an updated version. The previous revision, v3.3.3, remains accessible in the history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history. The 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' entry were removed from the page.SummaryDifference0.2%

- Check54 days agoChange DetectedA new revision entry v3.3.2 was added to the Study Record Version history, and revision v3.2.0 was removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding operating-status banner from the page. The underlying study history information remains unchanged.SummaryDifference0.7%

- Check83 days agoChange DetectedUpdates are limited to the record history, with new and revised versions and status notes; these do not change the core study details (e.g., eligibility, interventions, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check105 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status notice.SummaryDifference12%

Stay in the know with updates to Botensilimab for Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab for Advanced Melanoma Clinical Trial page.